Abbott Laboratories vs. Nurix Therapeutics, Inc. Common stock
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | NRIX | |
|---|---|---|
| Market Cap | $177.55 billion | $2.42 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | NRIX | |
|---|---|---|
| Dividend Yield | 2.45% | — |
ABT and NRIX split the dividend factors evenly.
Risk & Sentiment
| ABT | NRIX | |
|---|---|---|
| Short Interest | 0.57% | 1.54% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, NRIX overview, NRIX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
